SearchDictionaryMobileLogin

Miranda D Grounds Selected Research

Necrosis

07/2008Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle.
10/2006Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
08/2006Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.
11/2004Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
04/2004Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

Articles by Research Topic

Disease

5Necrosis
07/2008 - 04/2004
1Muscular Dystrophies (Muscular Dystrophy)
01/2008
1Inflammation
06/2005
1Atrophy
02/2005

Drug/Important Bio-Agent (IBA)

2TNFR-Fc fusion protein (etanercept)FDA Link
10/2006 - 06/2005
2infliximab (Remicade)FDA Link
06/2005 - 04/2004
2Insulin-Like Growth Factor I (IGF-1)IBA
02/2005 - 11/2004
1Insulin (Novolin)FDA Link
07/2008
1Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
08/2006

Therapy/Procedure

1Autologous Transplantation (Autograft)
01/2008
1Transplants (Transplant)
06/2005
1Denervation
02/2005